AI MARKET SCANNING

Scynexis Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.22%
MAX GAP RECORD +15.36%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SCYX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE)
+1.26%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
-7.28%
Mar 04, 2026 Earnings Release 2026-03-04 (AFTER CLOSE)
-4.52%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
-2.85%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
+2.49%
May 15, 2025 Earnings Release 2025-05-15 (AFTER CLOSE)
-8.89%
Mar 12, 2025 Earnings Release 2025-03-12 (AFTER CLOSE)
-0.44%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
-0.76%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.8%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SCYX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗